Indiana Trust & Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$678K Sell
11,769
-200
-2% -$11.5K 0.19% 91
2026
Q1
$726K Sell
11,969
-116
-1% -$6.76K 0.22% 81
2025
Q4
$652K Hold
12,085
0.19% 92
2025
Q3
$545K Hold
12,085
0.17% 99
2025
Q2
$559K Buy
12,085
+476
+4% +$23.4K 0.19% 95
2025
Q1
$708K Sell
11,609
-500
-4% -$29.1K 0.26% 77
2024
Q4
$685K Hold
12,109
0.23% 77
2024
Q3
$627K Sell
12,109
-1,982
-14% -$93K 0.21% 86
2024
Q2
$585K Sell
14,091
-1,595
-10% -$71.4K 0.21% 83
2024
Q1
$851K Sell
15,686
-158
-1% -$8.05K 0.34% 66
2023
Q4
$813K Sell
15,844
-290
-2% -$15.2K 0.37% 66
2023
Q3
$936K Sell
16,134
-1,157
-7% -$70.9K 0.47% 54
2023
Q2
$1.11M Sell
17,291
-450
-3% -$30.2K 0.56% 37
2023
Q1
$1.23M Sell
17,741
-237
-1% -$16.7K 0.67% 31
2022
Q4
$1.29K Sell
17,978
-752
-4% -$56.7K 0.73% 34
2022
Q3
$1.33M Sell
18,730
-1,429
-7% -$104K 0.81% 27
2022
Q2
$1.55M Hold
20,159
0.87% 24
2022
Q1
$1.47M Sell
20,159
-275
-1% -$18.5K 0.71% 30
2021
Q4
$1.27M Sell
20,434
-660
-3% -$38.7K 0.59% 37
2021
Q3
$1.25M Sell
21,094
-725
-3% -$47.7K 0.63% 32
2021
Q2
$1.35M Buy
21,819
+810
+4% +$52.8K 0.74% 31
2021
Q1
$1.33M Sell
21,009
-810
-4% -$50.4K 0.71% 30
2020
Q4
$1.35M Sell
21,819
-1,110
-5% -$68.3K 0.74% 31
2020
Q3
$1.38M Sell
22,929
-455
-2% -$27.4K 0.82% 29
2020
Q2
$1.38M Hold
23,384
0.85% 27
2020
Q1
$1.3M Sell
23,384
-75
-0.3% -$4.58K 0.93% 25
2019
Q4
$1.51M Buy
23,459
+9,522
+68% +$545K 0.84% 30
2019
Q3
$707K Buy
13,937
+50
+0.4% +$2.35K 0.4% 53
2019
Q2
$630K Hold
13,887
0.35% 62
2019
Q1
$663K Sell
13,887
-1,050
-7% -$52.3K 0.34% 59
2018
Q4
$776K Buy
14,937
+180
+1% +$9.67K 0.43% 55
2018
Q3
$916K Hold
14,757
0.42% 54
2018
Q2
$817K Sell
14,757
-520
-3% -$28.1K 0.39% 55
2018
Q1
$966K Buy
15,277
+1,455
+11% +$93.6K 0.45% 52
2017
Q4
$847K Buy
13,822
+550
+4% +$34.4K 0.39% 56
2017
Q3
$846K Hold
13,272
0.41% 54
2017
Q2
$740K Buy
13,272
+120
+0.9% +$6.53K 0.36% 60
2017
Q1
$715K Buy
13,152
+200
+2% +$11K 0.36% 59
2016
Q4
$757K Hold
12,952
0.39% 57
2016
Q3
$698K Hold
12,952
0.35% 64
2016
Q2
$953K Hold
12,952
0.48% 53
2016
Q1
$827K Hold
12,952
0.44% 58
2015
Q4
$765K Hold
12,952
0.4% 65
2015
Q3
$767K Hold
12,952
0.44% 57
2015
Q2
$862K Hold
12,952
0.45% 58
2015
Q1
$835K Hold
12,952
0.42% 59
2014
Q4
$765K Hold
12,952
0.4% 65
2014
Q3
$663K Hold
12,952
0.35% 69
2014
Q2
$628K Hold
12,952
0.36% 72
2014
Q1
$673K Buy
12,952
+1,500
+13% +$79.8K 0.42% 63
2013
Q4
$609K Hold
11,452
0.35% 64
2013
Q3
$530K Hold
11,452
0.32% 69
2013
Q2
$512K Buy
+11,452
New +$497K 0.42% 67

Other funds holding BMY

Indiana Trust & Investment Management's BMY Position: Q2 2026 in Review

Indiana Trust & Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $11.5K and leaving 11,769 shares worth $678K. The position accounts for 0.19% of the portfolio, ranked #91.

Indiana Trust & Investment Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.55M in Q2 2022. 1,403 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Indiana Trust & Investment Management held 11,769 shares of Bristol-Myers Squibb worth $678K as of Q2 2026.
  • Indiana Trust & Investment Management sold 200 Bristol-Myers Squibb shares in Q2 2026, an estimated $11.5K.
  • Bristol-Myers Squibb made up 0.19% of Indiana Trust & Investment Management's portfolio in Q2 2026, its #91 holding.
  • Indiana Trust & Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Indiana Trust & Investment Management's Bristol-Myers Squibb position peaked at $1.55M in Q2 2022.
  • 1,403 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Indiana Trust & Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.